🚶♂️💉 Giant Strides with Weekly Semaglutide Jabs!
Apr 05, 2025•3 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
🚶♂️ The STRIDE trial tested semaglutide in patients with PAD and type 2 diabetes.
💉 Weekly injections for 52 weeks improved walking distance, pain-free mobility, and quality of life.
📊 Results showed significant gains vs placebo, with low adverse events.
🌟 Semaglutide may offer a new stride forward in treating functional limitations in PAD.
For the best experience, listen in Metacast app for iOS or Android